屋漏偏逢连夜雨
MIST Receives Refusal to File Letter from FDA for NDA for Etripamil in the Treatment of PSVT$Milestone制药(MIST)$ 也辛苦他们合作伙伴了
| 发布于: | Android | 转发：0 | 回复：2 | 喜欢：0 |
屋漏偏逢连夜雨
MIST Receives Refusal to File Letter from FDA for NDA for Etripamil in the Treatment of PSVT$Milestone制药(MIST)$ 也辛苦他们合作伙伴了
名字就叫里程碑，可惜没到达